ArticleCancer chemotherapy and pharmacology2014

Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers.

Jennifer J Wheler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.